Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1089566

Utility of procalcitonin in a medical intensive care unit in Croatia


Vujaklija Brajković, Ana; Košuta, Iva; Tomek, Dora; Rora, Mia; Babel, Jakša; Rogić, Dunja; Lončar Vrančić, Ana; Radonić, Radovan
Utility of procalcitonin in a medical intensive care unit in Croatia // Wiener klinische Wochenschrift, 133 (2020), 15-16; 832-839 doi:10.1007/s00508-020-01747-1 (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 1089566 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Utility of procalcitonin in a medical intensive care unit in Croatia
(Utility of procalcitonin in a medical intensive care unit in Croatia)

Autori
Vujaklija Brajković, Ana ; Košuta, Iva ; Tomek, Dora ; Rora, Mia ; Babel, Jakša ; Rogić, Dunja ; Lončar Vrančić, Ana ; Radonić, Radovan

Izvornik
Wiener klinische Wochenschrift (0043-5325) 133 (2020), 15-16; 832-839

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
biomarker, prokalcitonin, sepsa, pneumonija, kritične bolesti
(Biomarker · Procalcitonin · Sepsis ·Pneumonia · Critical illness)

Sažetak
AimsTo investigate the clinical benefit of routine pro-calcitonin (PCT) measurement in the medical inten-sive care unit (ICU) of a tertiary referral hospital.MethodsAdult patients with suspected infectionswere included. White blood cells, C- reactive protein(CRP), and PCT were measured.ResultsIn this study 129 patients of median age 64years (interquartile range 39–89years) were prospec-tively included. The Acute Physiology And ChronicHealth Evaluation II (APACHE II) and Sequential Or-gan Failure Assessment (SOFA) scores were 21±14and 7± 6, respectively. Intensive care unit (ICU)mortality was 22.5%. Immunocompromised patientsconstituted 39.5%. A significant correlation was ob-served between PCT and APACHE II (Spearman’srho 0.461, p< 0.01), PCT and SOFA (Spearman’s rho0.494, p< 0.01) and PCT and CRP (Spearman’s rho0.403, p< 0.01). Most patients (n= 83, 64.3%) re-ceived antibiotics before admission. No differencein PCT (1.56± 8μg/L vs. 1.44± 13μg/L, p=0.6) wasobserved with respect to previous antibiotic ther-apy. Levels of PCT and CRP were significantly in-creased in patients with positive blood cultures, the infection caused by Gram-negative microorganismregardless of disease severity and pneumonia withcomplications. PCT did not differ among patientswith positive vs negative urine culture (4.6± 16μg/Lvs. 1.76± 11.9μg/L) or positive vs. negative endotra-cheal aspirate (1.93± 11.4μg/L vs. 1.76± 1.11μg/L).PCT-guided stewardship was applied in 36 patients(28%).ConclusionIncreased initial PCT levels might pointto the development of more severe disease caused byGram-negative bacteria, regardless of previous antibi-otic treatment. The results pertain to immunocompe-tent and immunocompromised patients. Implemen-tation of PCT-guided stewardship in those patients ispossible and relies on experience as well as knowl-edge of reference change value for a marker withinthe specific setting.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Ustanove:
Medicinski fakultet, Zagreb,
Klinički bolnički centar Zagreb

Poveznice na cjeloviti tekst rada:

doi

Citiraj ovu publikaciju:

Vujaklija Brajković, Ana; Košuta, Iva; Tomek, Dora; Rora, Mia; Babel, Jakša; Rogić, Dunja; Lončar Vrančić, Ana; Radonić, Radovan
Utility of procalcitonin in a medical intensive care unit in Croatia // Wiener klinische Wochenschrift, 133 (2020), 15-16; 832-839 doi:10.1007/s00508-020-01747-1 (međunarodna recenzija, članak, znanstveni)
Vujaklija Brajković, A., Košuta, I., Tomek, D., Rora, M., Babel, J., Rogić, D., Lončar Vrančić, A. & Radonić, R. (2020) Utility of procalcitonin in a medical intensive care unit in Croatia. Wiener klinische Wochenschrift, 133 (15-16), 832-839 doi:10.1007/s00508-020-01747-1.
@article{article, author = {Vujaklija Brajkovi\'{c}, Ana and Ko\v{s}uta, Iva and Tomek, Dora and Rora, Mia and Babel, Jak\v{s}a and Rogi\'{c}, Dunja and Lon\v{c}ar Vran\v{c}i\'{c}, Ana and Radoni\'{c}, Radovan}, year = {2020}, pages = {832-839}, DOI = {10.1007/s00508-020-01747-1}, keywords = {biomarker, prokalcitonin, sepsa, pneumonija, kriti\v{c}ne bolesti}, journal = {Wiener klinische Wochenschrift}, doi = {10.1007/s00508-020-01747-1}, volume = {133}, number = {15-16}, issn = {0043-5325}, title = {Utility of procalcitonin in a medical intensive care unit in Croatia}, keyword = {biomarker, prokalcitonin, sepsa, pneumonija, kriti\v{c}ne bolesti} }
@article{article, author = {Vujaklija Brajkovi\'{c}, Ana and Ko\v{s}uta, Iva and Tomek, Dora and Rora, Mia and Babel, Jak\v{s}a and Rogi\'{c}, Dunja and Lon\v{c}ar Vran\v{c}i\'{c}, Ana and Radoni\'{c}, Radovan}, year = {2020}, pages = {832-839}, DOI = {10.1007/s00508-020-01747-1}, keywords = {Biomarker · Procalcitonin · Sepsis ·Pneumonia · Critical illness}, journal = {Wiener klinische Wochenschrift}, doi = {10.1007/s00508-020-01747-1}, volume = {133}, number = {15-16}, issn = {0043-5325}, title = {Utility of procalcitonin in a medical intensive care unit in Croatia}, keyword = {Biomarker · Procalcitonin · Sepsis ·Pneumonia · Critical illness} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font